References
  1. Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clinical microbiology reviews. 2011;24(2):351-76.
  2. Meda ZC, Sombie I, Sanon OW, Mare D, Morisky DE, Chen YM. Risk factors of tuberculosis infection among HIV/AIDS patients in Burkina Faso. AIDS research and human retroviruses. 2013;29(7):1045-55.
  3. WHO: WHO policy on collaborative TB/HIV activities, Guidelines for national programs, and other stakeholders. Geneva, Switzerland: World Health Organization; 2012
  4. WHO: TB/HIV, HIV-Associated Tuberculosis Fact Sheet. Geneva, Switzerland: World Health Organization; 2018.
  5. WHO: Global Tuberculosis Report. Geneva, Switzerland: World Health Organization; 2019.
  6. WHO: Global Tuberculosis Report. Geneva, Switzerland: World Health Organization; 2018.
  7. Alene KA, Viney K, Moore HC, Wagaw M, Clements ACA. Spatial patterns of tuberculosis and HIV co-infection in Ethiopia. PLoS One. 2019;14(12):e0226127.
  8. Alemu YM, Awoke W, Wilder-Smith A. Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case-control study. BMJ Open. 2016;6(4):e009058.
  9. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. The Lancet. 2002;359(9323):2059-64.
  10. Cui Z, Lin M, Nie S, Lan R. Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China. PLoS One. 2017;12(3):e0173976.
  11. Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, et al (2007) Impact of Antiretroviral Therapy on the Incidence of Tuberculosis: The Brazilian Experience, 1995–2001. PLoS ONE.2007; 2(9): e826. DOI:10.1371/journal.pone.0000826
  12. del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, et al. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012;54(9):1364-72.
  13. Alemu A, Yesuf A, Zerihun B, Getu M, Worku T, Bitew ZW. Incidence and determinants of tuberculosis among HIV-positive individuals in Addis Ababa, Ethiopia: A retrospective cohort study. International Journal of Infectious Diseases. 2020;95:59-66.
  14. Taha M, Deribew A, Tessema F, Assegid S, Duchateau L, Colebunders R. Risk factors of active tuberculosis in people living with HIV/AIDS in southwest Ethiopia: a case-control study. Ethiop J Health Science 2011; 21(2).
  15. Yirdaw KD, Teklu AM, Mamuye AT, Zewdu S. Breakthrough tuberculosis disease among people with HIV - Should we be worried? A retrospective longitudinal study. PLoS One. 2019;14(2):e0211688.
  16. Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case-control study. PLoS One. 2013;8(5):e64488.
  17. Azanaw MM, Derseh NM, Yetemegn GS, Angaw DA. Incidence and Predictors of tuberculosis among HIV patients after initiation of ART treatment in Ethiopia: A systematic review and Meta-analysis. Research square, a preprint 2020; DOI: 10.21203/rs.2.19054/v1
  18. Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia. African health sciences. 2016;16(2):588-95.
  19. Aemro A, Jember A, Anlay DZ. Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):245.
  20. Girardi E,  Sabin CA,  Monforte AA,  Hogg B,  Phillips AN, et al. Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America. Clinical Infectious Diseases 2005;41:1772–82.
  21. Alene KA, Nega A, Taye BW. Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect Dis . 2013;13:292.
  22. Kassa A, Teka A, Shewaamare A, Jerene D. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg. 2012;106(6):363-70.
  23. Ahmed A, Mekonnen D, Shiferaw AM, Belayneh F, Yenit MK. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study. BMJ Open. 2018;8(2):e016961.
  24. Alene KA, Nega A, Taye BW. Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect Dis 2013;13:292.
  25. Federal Democratic Republic of Ethiopia Ministry of Health; National Comprehensive Tuberculosis, Leprosy and TB/HIV Training Manual for Health Care Workers. 201626.
  26. Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Am J Respir Crit Care Med. 2005;172(1):123-7.
  27. Nugus GG, Irena ME. Determinants of Active Tuberculosis Occurrences after ART Initiation among Adult HIV-Positive Clients in West Showa Zone Public Hospitals, Ethiopia: A Case-Control Study. Advances in Public Health. 2020;2020:1-8.
  28. Unis G, Ribeiro AW, Esteves LS, et al. Tuberculosis recurrence in a high incidence setting for HIV and tuberculosis in Brazil. BMC Infectious Diseases . 2014, 14:548.
  29. Brinkhof MWG,  Egger E,  Boulle A, May M, Hosseinipour M, et al.Tuberculosis after Initiation of Antiretroviral Therapy in Low-Income and High-Income Countries. Clinical Infectious Diseases. 2007;45(11):1518-21.
  30. Tiruneh G, Getahun A, Adeba E. Assessing the Impact of Isoniazid Preventive Therapy (IPT) on Tuberculosis Incidence and Predictors of Tuberculosis among Adult Patients Enrolled on ART in Nekemte Town, Western Ethiopia: A Retrospective Cohort Study. Interdisciplinary perspectives on infectious diseases. 2019;2019:1413427.
  31. Gunda DW, Maganga SC, Nkandala I, Kilonzo SB, Mpondo BC, Shao ER, et al. Prevalence and Risk Factors of Active TB among Adult HIV Patients Receiving ART in Northwestern Tanzania: A Retrospective Cohort Study. The Canadian journal of infectious diseases & medical microbiology. 2018;2018:1346104.
  32. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. Journal of acquired immune deficiency syndromes (1999). 2009;52(2):280-9.
  33. Hu X, Liang B, Zhou C, Jiang J, Huang J, Ning C, et al. HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study. AIDS research and therapy. 2019;16(1):6.
  34. Dravid A, Natarajan K, Medisetty M, Gawali R, Mahajan U, Kulkarni M, et al. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. BMC Infect Dis. 2019;19(1):714.
  35. WHO: Implementing the WHO Stop TB Strategy. Geneva, Switzerland: World Health Organization; 2008.
  36. Pettit AC, Jenkins CA, Stinnette SE, Rebeiro PF, Blackwell RB, Raffanti SP, et al. Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting? Journal of acquired immune deficiency syndromes. 2011;57(4):305-10.
  37. Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. Journal of acquired immune deficiency syndromes. 2011;56(4):349-55.
  38. Ali K, Klotz SA. The immune reconstitution inflammatory syndrome with tuberculosis: a common problem in Ethiopian HIV-infected patients beginning antiretroviral therapy. J Int Assoc Physicians AIDS Care (Chic). 2012;11(3):198-202.